On November 1, Paradise Hospital and Paradise Pediatric Specialty Hospital in Oriental New Town opened in a low-key manner.

The former will aim to be the world's highest level pediatric hospital, treating children with incurable diseases, and will be charitable in nature, generally waiving some or all of the medical expenses if the patient's family is in financial difficulty.

The latter is not an ordinary hospital, but actually a medical institution with a practical and scientific research nature, and it is also a kind of pioneering exploration of the future medical system by Ye Quan.

Paradise Hospital uses a lot of new technology, equipment, and methods, like Wesley's Lerman Hospital, with many extremely advanced but not mysterious medical procedures.

The biggest advantage of the hospital is that it has a medical system super intelligent brain "Bian Que", the hospital routine inspection application intelligent system diagnosis, no need for doctors, no need for registration, and the cost is only some intelligent brain computing electricity bills, the accuracy rate is as high as 99%.

"Bian Que" can quickly interpret the patient's medical records, analyze relevant information and medical literature, and accurately calculate various medical plans and possible outcomes.

As long as it is connected to the Internet, easy-to-use, and low-cost mobile medical diagnostic equipment, Bian Que can diagnose patients who are far away from the city and lack basic medical facilities, and even at home, they can diagnose on their own.

With Super Brain, the average patient no longer needs to queue up in an overcrowded emergency room.

Medical knowledge is growing exponentially, and any doctor has limitations and it is impossible to be proficient in all and medical information.

Every year, the number of deaths due to medical negligence is staggering, and it is impossible to count diagnostic and medication errors.

As a matter of fact. Only about a quarter of the diseases facing humanity can be traced to their causes. About one-tenth of these can be treated for the cause. The rest can only be treated symptomatically, which further limits the doctor.

Of course, the current health care system, more, worse, is the shortage of doctors.

With the computing power of "Bian Que", if conditions permit, hundreds of thousands of patients can be evaluated at the same time, a correct diagnosis can be made, and a treatment plan can be tailored to each patient.

The main direction that Paradise Hospital is currently tackling is organ transplantation. It already has a mature artificial organ transplantation technology, through the patient's genes and stem cells, in the real yàn room with a biological 3D printer to print simple living tissues such as bones, skin, muscles and blood vessel fragments, as well as large human organs such as kidneys (accounting for 80% of the need for transplanted organs), liver and even heart, and then replace the necrotic organs in the patient's body with the cultivated organs, and there is no rejection.

In Ye Quan's plan, dozens of serious diseases such as leukemia, heart disease, and diabetes will be led by Paradise Hospital in a few years to completely solve these medical problems.

The hospital also has several advanced surgical machines. Some simple, repetitive surgeries are completely replaced by machine qì people.

Of course. With a surgical machine, it does not mean that doctors can be replaced, but that the ability of surgeons can be further improved.

For complex surgeries, surgeons cooperate with intelligent surgical systems, with functions such as virtual magnified images and voice instructions, which can complete the operation accurately and quickly, and can also perform remote surgery on patients in remote areas through guò video.

This is very useful on the battlefield, where the doctor in the rear is in a safe area, which can easily provide timely rescue for wounded soldiers on the front line.

In the future, there will be more, smaller, and more professional surgical machines.

It won't be long before the whole world will know about these two hospitals and see them as medical mecca.

On the same day, Taoyuan weight loss drugs were officially launched, and soon became a sought-after commodity for obesity patients, because of the production problem, it can only meet the domestic market for the time being, plus foreign approval problems, and there is no hope for export.

This has caused dissatisfaction among many foreign patients, and they have rushed to Xinhua to buy them.

More and more examples of successful weight loss have set off a global weight loss boom for Taoyuan Pharmaceutical Company, and then announced its entry into the vaccine market.

This is an area that Ye Quan is very concerned about.

In December 13, 17 newborns died due to hepatitis B vaccination, but the government finally declared in the investigation report that the cause of death of the babies was not related to the vaccine and was a coincidental disease.

Since it is unrelated, it does not explain why these 17 babies died in a short period of time after being vaccinated?

Ye Quan then went to learn about the situation of the domestic vaccine industry, and the results shocked him.

First of all, from a medical point of view, not every baby needs to be vaccinated against hepatitis B, but only if the mother is a carrier of hepatitis B, and 93.4% of mothers are not carriers of hepatitis B.

Second, the vaccine market is completely controlled by the government, and vaccine manufacturers form oligopolies in their respective provinces and regions, because once the relationship is opened, there is no competitive pressure, there is no technological progress, and there is no incentive to do expensive vaccine research.

Many vaccines are still using the "live attenuated vaccine" technology of the sixties and seventies of the last century, while foreign countries have long been fully changed to "inactivated vaccine" technology, which is much safer, and the adverse reaction rate of vaccines in some developed countries is only one in three million.

In addition, foreign countries in the eighties of the last century developed a combination of vaccines, there are three, five, six vaccines and other vaccines, that is to say, only one vaccine can prevent several diseases, while Xinhua's vaccine can only prevent one, the research of combined vaccines has just begun, and the market has been monopolized by foreign capital.

Parents who can afford it often have no confidence in domestic vaccines and prefer to use expensive imported vaccines for the safety of their children.

The combination vaccine developed by Taoyuan Pharmaceutical Company can reduce the adverse reaction rate to less than 1 in 10 million, which can basically eliminate the danger and do not need to be frozen for transportation.

Some remote and impoverished areas are unable to store vaccines because of lack of electricity and refrigeration equipment, which brings great difficulties to local vaccination work.

The more far-term research of Taoyuan Pharmaceutical Company is to develop a fruit vaccine, which does not need to be refrigerated, as long as the child eats a specially cultivated fruit, it can generate immunity in the body, prevent diseases, and taste very delicious.

The key to oral vaccines is that after the antigen is eaten into the stomach, it can avoid the attack of digestive juices and reach the mucous membrane of the human body, stimulating the body's defense mechanism to produce antibodies.

All children don't like injections, and in fact, few adults like injections.

What's more, vaccinations can easily lead to infection. According to statistics, there are millions of cases of infection in the world every year due to vaccination.

In the past two decades, biotechnology has developed tremendously, and the intersection of medicine, botany, molecular biology and food science has made great progress in the research of fruit and vegetable vaccines, which is enough to show that it is completely feasible to produce oral vaccines from plants, and has great potential.

However, fruit vaccines are still a long way from commercial production, and Taoyuan Pharmaceutical will strive to take the lead. (To be continued......)